Search Results - "O’Halloran, Eileen A."

Tumor mutational burden and somatic mutation status to predict disease recurrence in advanced melanoma by Hotz, Meghan J., O’Halloran, Eileen A., Hill, Maureen V., Hayden, Kelly, Zaladonis, Angela G., Deng, Mengying, Olszanski, Anthony J., Reddy, Sanjay S., Wu, Hong, Luo, Biao, Farma, Jeffrey M.

“…Tumor mutational burden (TMB) has recently been identified as a biomarker of response to immune checkpoint inhibitors in many cancers, including melanoma…”
Get full text

Perfect Episodes of Care in Pancreatic Surgery by O'Halloran, Eileen A., Bland, Joseph E., Hill, Maureen V., Reddy, Sanjay S.

Get full text

Predicting positive peritoneal cytology in pancreatic cancer by O’Halloran, Eileen A., Board, Tamsin, Lefton, Max, Devarajan, Karthik, Dotan, Efrat, Meyer, Joshua, Reddy, Sanjay S.

“…Introduction Positive cytology from peritoneal washings obtained prior to potential resection of pancreatic cancer is associated with grim prognosis,…”
Get full text

Four hundred fifty-three consecutive pancreaticoduodenectomies with pancreaticogastrostomy by Eguia, Emanuel, O'Halloran, Eileen A., Borge, Marc A., Micetich, Kenneth, Aranha, Gerard V.

“…Patients who undergo pancreaticoduodenectomy (PD) have the pancreatic remnant (PR) anastomosed to the jejunum. In this study, all patients had the PR…”
Get full text

1173 OPTIMAL TIME TO SURGERY AFTER NEOADJUVANT THERAPY IN PANCREATIC ADENOCARCINOMA: IS THERE AN IDEAL WINDOW? by Crocker, Andrew B., Winer, Leah, O'Halloran, Eileen A., Barrak, Dany, Devarajan, Karthik, Reddy, Sanjay S.

Get full text

301 PANCREATICOJEJUNOSTOMY: INTRODUCING A NOVEL TECHNIQUE WITH LOW PANCREATIC FISTULA RATE by Moslim, Maitham A., Lefton, Max D., O'Halloran, Eileen A., Ross, Eric A., Board, Tamsin, Karachristos, Andreas, Reddy, Sanjay S.

Get full text

Preoperative Opioid Use in Patients Undergoing Surgical Resection for Treatment of Rectal Cancer by Hill, Maureen V., O'Halloran, Eileen A., Reddy, Sanjay S., Sigurdson, Elin R., Farma, Jeffrey

Get full text

Tumor mutational burden and somatic mutation status to predict disease recurrence in advanced melanoma by Hotz, Meghan J., O’Halloran, Eileen A., Hill, Maureen V., Hayden, Kelly, Zaladonis, Angela G., Deng, Mengying, Olszanski, Anthony J., Reddy, Sanjay S., Wu, Hong, Luo, Biao, Farma, Jeffrey M.

“…Tumor mutational burden (TMB) has recently been identified as a biomarker of response to immune checkpoint inhibitors in many cancers, including melanoma…”
Get full text

Chapter 60 - Inguinal and Pelvic Lymphadenectomy by O’Halloran, Eileen A., Farma, Jeffrey M.

“…This chapter provides an overview of the technical and anatomic aspects of an inguinal and pelvic lymph node dissection…”
Get full text

Inguinal and Pelvic Lymphadenectomy by O’Halloran, Eileen A, Farma, Jeffrey M

Get full text